Skip to main content
Top
Published in: Diabetologia 10/2017

01-10-2017 | Article

ERK1 is dispensable for mouse pancreatic beta cell function but is necessary for glucose-induced full activation of MSK1 and CREB

Authors: Michele Leduc, Joy Richard, Safia Costes, Dany Muller, Annie Varrault, Vincent Compan, Julia Mathieu, Jean-François Tanti, Gilles Pagès, Jacques Pouyssegur, Gyslaine Bertrand, Stéphane Dalle, Magalie A. Ravier

Published in: Diabetologia | Issue 10/2017

Login to get access

Abstract

Aims/hypothesis

Insufficient insulin secretion from pancreatic beta cells, which is associated with a decrease in beta cell mass, is a characteristic of type 2 diabetes. Extracellular signal-related kinase 1 and 2 (ERK1/2) inhibition in beta cells has been reported to affect insulin secretion, gene transcription and survival, although whether ERK1 and ERK2 play distinct roles is unknown. The aim of this study was to assess the individual roles of ERK1 and ERK2 in beta cells using ERK1 (also known as Mapk3)-knockout mice (Erk1 −/− mice) and pharmacological approaches.

Methods

NAD(P)H, free cytosolic Ca2+ concentration and insulin secretion were determined in islets. ERK1 and ERK2 subplasmalemmal translocation and activity was monitored using total internal reflection fluorescence microscopy. ERK1/2, mitogen and stress-activated kinase1 (MSK1) and cAMP-responsive element-binding protein (CREB) activation were evaluated by western blot and/or immunocytochemistry. The islet mass was determined from pancreatic sections.

Results

Glucose induced rapid subplasmalemmal recruitment of ERK1 and ERK2. When both ERK1 and ERK2 were inhibited simultaneously, the rapid transient peak of the first phase of glucose-induced insulin secretion was reduced by 40% (p < 0.01), although ERK1 did not appear to be involved in this process. By contrast, ERK1 was required for glucose-induced full activation of several targets involved in beta cell survival; MSK1 and CREB were less active in Erk1 −/− mouse beta cells (p < 0.01) compared with Erk1 +/+ mouse beta cells, and their phosphorylation could only be restored when ERK1 was re-expressed and not when ERK2 was overexpressed. Finally, the islet mass of Erk1 −/− mice was slightly increased in young animals (4-month-old mice) vs Erk1 +/+ mice (section occupied by islets [mean ± SEM]: 0.74% ± 0.03% vs 0.62% ± 0.04%; p < 0.05), while older mice (10 months old) were less prone to age-associated pancreatic peri-insulitis (infiltrated islets [mean ± SEM]: 7.51% ± 1.34% vs 2.03% ± 0.51%; p < 0.001).

Conclusions/interpretation

ERK1 and ERK2 play specific roles in beta cells. ERK2 cannot always compensate for the lack of ERK1 but the absence of a clear-cut phenotype in Erk1 −/− mice shows that ERK1 is dispensable in normal conditions.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Henquin JC (2011) The dual control of insulin secretion by glucose involves triggering and amplifying pathways in β-cells. Diabetes Res Clin Pract 93(Suppl 1):S27–S31CrossRefPubMed Henquin JC (2011) The dual control of insulin secretion by glucose involves triggering and amplifying pathways in β-cells. Diabetes Res Clin Pract 93(Suppl 1):S27–S31CrossRefPubMed
3.
go back to reference Gilon P, Chae HY, Rutter GA, Ravier MA (2014) Calcium signaling in pancreatic β-cells in health and in type 2 diabetes. Cell Calcium 56:340–361CrossRefPubMed Gilon P, Chae HY, Rutter GA, Ravier MA (2014) Calcium signaling in pancreatic β-cells in health and in type 2 diabetes. Cell Calcium 56:340–361CrossRefPubMed
4.
5.
go back to reference Lawrence M, Shao C, Duan L, McGlynn K, Cobb MH (2008) The protein kinases ERK1/2 and their roles in pancreatic beta cells. Acta Physiol (Oxf) 192:11–17CrossRef Lawrence M, Shao C, Duan L, McGlynn K, Cobb MH (2008) The protein kinases ERK1/2 and their roles in pancreatic beta cells. Acta Physiol (Oxf) 192:11–17CrossRef
6.
go back to reference Briaud I, Lingohr MK, Dickson LM, Wrede CE, Rhodes CJ (2003) Differential activation mechanisms of Erk-1/2 and p70(S6K) by glucose in pancreatic β-cells. Diabetes 52:974–983CrossRefPubMed Briaud I, Lingohr MK, Dickson LM, Wrede CE, Rhodes CJ (2003) Differential activation mechanisms of Erk-1/2 and p70(S6K) by glucose in pancreatic β-cells. Diabetes 52:974–983CrossRefPubMed
7.
go back to reference Kowluru A, Veluthakal R, Rhodes CJ et al (2010) Protein farnesylation-dependent Raf/extracellular signal-related kinase signaling links to cytoskeletal remodeling to facilitate glucose-induced insulin secretion in pancreatic β-cells. Diabetes 59:967–977CrossRefPubMedCentralPubMed Kowluru A, Veluthakal R, Rhodes CJ et al (2010) Protein farnesylation-dependent Raf/extracellular signal-related kinase signaling links to cytoskeletal remodeling to facilitate glucose-induced insulin secretion in pancreatic β-cells. Diabetes 59:967–977CrossRefPubMedCentralPubMed
8.
go back to reference Longuet C, Broca C, Costes S et al (2005) Extracellularly regulated kinases 1/2 (p44/42 mitogen-activated protein kinases) phosphorylate synapsin I and regulate insulin secretion in the MIN6 β-cell line and islets of Langerhans. Endocrinology 146:643–654CrossRefPubMed Longuet C, Broca C, Costes S et al (2005) Extracellularly regulated kinases 1/2 (p44/42 mitogen-activated protein kinases) phosphorylate synapsin I and regulate insulin secretion in the MIN6 β-cell line and islets of Langerhans. Endocrinology 146:643–654CrossRefPubMed
9.
go back to reference Tomas A, Yermen B, Min L, Pessin JE, Halban PA (2006) Regulation of pancreatic β-cell insulin secretion by actin cytoskeleton remodelling: role of gelsolin and cooperation with the MAPK signalling pathway. J Cell Sci 119:2156–2167CrossRefPubMed Tomas A, Yermen B, Min L, Pessin JE, Halban PA (2006) Regulation of pancreatic β-cell insulin secretion by actin cytoskeleton remodelling: role of gelsolin and cooperation with the MAPK signalling pathway. J Cell Sci 119:2156–2167CrossRefPubMed
10.
go back to reference Bowe JE, Chander A, Liu B, Persaud SJ, Jones PM (2013) The permissive effects of glucose on receptor-operated potentiation of insulin secretion from mouse islets: a role for ERK1/2 activation and cytoskeletal remodelling. Diabetologia 56:783–791CrossRefPubMed Bowe JE, Chander A, Liu B, Persaud SJ, Jones PM (2013) The permissive effects of glucose on receptor-operated potentiation of insulin secretion from mouse islets: a role for ERK1/2 activation and cytoskeletal remodelling. Diabetologia 56:783–791CrossRefPubMed
11.
go back to reference Benes C, Roisin MP, Van Tan H et al (1998) Rapid activation and nuclear translocation of mitogen-activated protein kinases in response to physiological concentration of glucose in the MIN6 pancreatic beta cell line. J Biol Chem 273:15507–15513CrossRefPubMed Benes C, Roisin MP, Van Tan H et al (1998) Rapid activation and nuclear translocation of mitogen-activated protein kinases in response to physiological concentration of glucose in the MIN6 pancreatic beta cell line. J Biol Chem 273:15507–15513CrossRefPubMed
12.
go back to reference Wauson EM, Guerra ML, Barylko B, Albanesi JP, Cobb MH (2013) Off-target effects of MEK inhibitors. Biochemistry 52:5164–5166CrossRefPubMed Wauson EM, Guerra ML, Barylko B, Albanesi JP, Cobb MH (2013) Off-target effects of MEK inhibitors. Biochemistry 52:5164–5166CrossRefPubMed
13.
go back to reference Yoon S, Seger R (2006) The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 24:21–44CrossRefPubMed Yoon S, Seger R (2006) The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 24:21–44CrossRefPubMed
14.
go back to reference Cargnello M, Roux PP (2011) Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev 75:50–83CrossRefPubMedCentralPubMed Cargnello M, Roux PP (2011) Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev 75:50–83CrossRefPubMedCentralPubMed
15.
go back to reference Busca R, Christen R, Lovern M et al (2015) ERK1 and ERK2 present functional redundancy in tetrapods despite higher evolution rate of ERK1. BMC Evol Biol 15:179CrossRefPubMedCentralPubMed Busca R, Christen R, Lovern M et al (2015) ERK1 and ERK2 present functional redundancy in tetrapods despite higher evolution rate of ERK1. BMC Evol Biol 15:179CrossRefPubMedCentralPubMed
16.
go back to reference Fremin C, Saba-El-Leil MK, Levesque K, Ang SL, Meloche S (2015) Functional redundancy of ERK1 and ERK2 MAP kinases during development. Cell Rep 12:913–921CrossRefPubMed Fremin C, Saba-El-Leil MK, Levesque K, Ang SL, Meloche S (2015) Functional redundancy of ERK1 and ERK2 MAP kinases during development. Cell Rep 12:913–921CrossRefPubMed
17.
go back to reference Imamura O, Pages G, Pouyssegur J, Endo S, Takishima K (2010) ERK1 and ERK2 are required for radial glial maintenance and cortical lamination. Genes Cells 15:1072–1088CrossRefPubMed Imamura O, Pages G, Pouyssegur J, Endo S, Takishima K (2010) ERK1 and ERK2 are required for radial glial maintenance and cortical lamination. Genes Cells 15:1072–1088CrossRefPubMed
18.
go back to reference Saba-El-Leil MK, Vella FD, Vernay B et al (2003) An essential function of the mitogen-activated protein kinase ERK2 in mouse trophoblast development. EMBO Rep 4:964–968CrossRefPubMedCentralPubMed Saba-El-Leil MK, Vella FD, Vernay B et al (2003) An essential function of the mitogen-activated protein kinase ERK2 in mouse trophoblast development. EMBO Rep 4:964–968CrossRefPubMedCentralPubMed
19.
go back to reference Pages G, Guerin S, Grall D et al (1999) Defective thymocyte maturation in p44 MAP kinase (ERK1) knockout mice. Science 286:1374–1377CrossRefPubMed Pages G, Guerin S, Grall D et al (1999) Defective thymocyte maturation in p44 MAP kinase (ERK1) knockout mice. Science 286:1374–1377CrossRefPubMed
20.
go back to reference Bost F, Aouadi M, Caron L et al (2005) The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis. Diabetes 54:402–411CrossRefPubMed Bost F, Aouadi M, Caron L et al (2005) The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis. Diabetes 54:402–411CrossRefPubMed
21.
go back to reference Boulton TG, Nye SH, Robbins DJ et al (1991) ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65:663–675CrossRefPubMed Boulton TG, Nye SH, Robbins DJ et al (1991) ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65:663–675CrossRefPubMed
22.
go back to reference Costes S, Broca C, Bertrand G et al (2006) ERK1/2 control phosphorylation and protein level of cAMP-responsive element-binding protein: a key role in glucose-mediated pancreatic β-cell survival. Diabetes 55:2220–2230CrossRefPubMed Costes S, Broca C, Bertrand G et al (2006) ERK1/2 control phosphorylation and protein level of cAMP-responsive element-binding protein: a key role in glucose-mediated pancreatic β-cell survival. Diabetes 55:2220–2230CrossRefPubMed
23.
go back to reference Jager J, Corcelle V, Gremeaux T et al (2011) Deficiency in the extracellular signal-regulated kinase 1 (ERK1) protects leptin-deficient mice from insulin resistance without affecting obesity. Diabetologia 54:180–189CrossRefPubMed Jager J, Corcelle V, Gremeaux T et al (2011) Deficiency in the extracellular signal-regulated kinase 1 (ERK1) protects leptin-deficient mice from insulin resistance without affecting obesity. Diabetologia 54:180–189CrossRefPubMed
24.
go back to reference Kanda Y, Shimoda M, Tawaramoto K et al (2009) Molecular analysis of db gene-related pancreatic beta cell dysfunction; evidence for a compensatory mechanism inhibiting development of diabetes in the db gene heterozygote. Endocr J 56:997–1008CrossRefPubMed Kanda Y, Shimoda M, Tawaramoto K et al (2009) Molecular analysis of db gene-related pancreatic beta cell dysfunction; evidence for a compensatory mechanism inhibiting development of diabetes in the db gene heterozygote. Endocr J 56:997–1008CrossRefPubMed
25.
go back to reference Satoh Y, Endo S, Nakata T et al (2011) ERK2 contributes to the control of social behaviors in mice. J Neurosci 31:11953–11967CrossRefPubMed Satoh Y, Endo S, Nakata T et al (2011) ERK2 contributes to the control of social behaviors in mice. J Neurosci 31:11953–11967CrossRefPubMed
26.
go back to reference Ripple MO, Kim N, Springett R (2013) Acute mitochondrial inhibition by mitogen-activated protein kinase/extracellular signal-regulated kinase (MEK) 1/2 inhibitors regulates proliferation. J Biol Chem 288:2933–2940CrossRefPubMed Ripple MO, Kim N, Springett R (2013) Acute mitochondrial inhibition by mitogen-activated protein kinase/extracellular signal-regulated kinase (MEK) 1/2 inhibitors regulates proliferation. J Biol Chem 288:2933–2940CrossRefPubMed
27.
go back to reference Yamaguchi T, Kakefuda R, Tajima N, Sowa Y, Sakai T (2011) Antitumor activities of JTP-74057 (GSK1120212), a novel MEK1/2 inhibitor, on colorectal cancer cell lines in vitro and in vivo. Int J Oncol 39:23–31PubMed Yamaguchi T, Kakefuda R, Tajima N, Sowa Y, Sakai T (2011) Antitumor activities of JTP-74057 (GSK1120212), a novel MEK1/2 inhibitor, on colorectal cancer cell lines in vitro and in vivo. Int J Oncol 39:23–31PubMed
29.
30.
go back to reference Ravier MA, Tsuboi T, Rutter GA (2008) Imaging a target of Ca2+ signalling: dense core granule exocytosis viewed by total internal reflection fluorescence microscopy. Methods 46:233–238CrossRefPubMedCentralPubMed Ravier MA, Tsuboi T, Rutter GA (2008) Imaging a target of Ca2+ signalling: dense core granule exocytosis viewed by total internal reflection fluorescence microscopy. Methods 46:233–238CrossRefPubMedCentralPubMed
31.
go back to reference Arthur JS, Cohen P (2000) MSK1 is required for CREB phosphorylation in response to mitogens in mouse embryonic stem cells. FEBS Lett 482:44–48CrossRefPubMed Arthur JS, Cohen P (2000) MSK1 is required for CREB phosphorylation in response to mitogens in mouse embryonic stem cells. FEBS Lett 482:44–48CrossRefPubMed
32.
go back to reference Diraison F, Parton L, Ferre P et al (2004) Over-expression of sterol-regulatory-element-binding protein-1c (SREBP1c) in rat pancreatic islets induces lipogenesis and decreases glucose-stimulated insulin release: modulation by 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR). Biochem J 378:769–778CrossRefPubMedCentralPubMed Diraison F, Parton L, Ferre P et al (2004) Over-expression of sterol-regulatory-element-binding protein-1c (SREBP1c) in rat pancreatic islets induces lipogenesis and decreases glucose-stimulated insulin release: modulation by 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR). Biochem J 378:769–778CrossRefPubMedCentralPubMed
33.
go back to reference Jhala US, Canettieri G, Screaton RA et al (2003) cAMP promotes pancreatic β-cell survival via CREB-mediated induction of IRS2. Genes Dev 17:1575–1580CrossRefPubMedCentralPubMed Jhala US, Canettieri G, Screaton RA et al (2003) cAMP promotes pancreatic β-cell survival via CREB-mediated induction of IRS2. Genes Dev 17:1575–1580CrossRefPubMedCentralPubMed
34.
go back to reference Jambal P, Masterson S, Nesterova A et al (2003) Cytokine-mediated down-regulation of the transcription factor cAMP-response element-binding protein in pancreatic β-cells. J Biol Chem 278:23055–23065CrossRefPubMed Jambal P, Masterson S, Nesterova A et al (2003) Cytokine-mediated down-regulation of the transcription factor cAMP-response element-binding protein in pancreatic β-cells. J Biol Chem 278:23055–23065CrossRefPubMed
35.
go back to reference Dalle S, Longuet C, Costes S et al (2004) Glucagon promotes cAMP-response element-binding protein phosphorylation via activation of ERK1/2 in MIN6 cell line and isolated islets of Langerhans. J Biol Chem 279:20345–20355CrossRefPubMed Dalle S, Longuet C, Costes S et al (2004) Glucagon promotes cAMP-response element-binding protein phosphorylation via activation of ERK1/2 in MIN6 cell line and isolated islets of Langerhans. J Biol Chem 279:20345–20355CrossRefPubMed
36.
go back to reference Shin S, Le Lay J, Everett LJ et al (2014) CREB mediates the insulinotropic and anti-apoptotic effects of GLP-1 signaling in adult mouse β-cells. Mol Metab 3:803–812CrossRefPubMedCentralPubMed Shin S, Le Lay J, Everett LJ et al (2014) CREB mediates the insulinotropic and anti-apoptotic effects of GLP-1 signaling in adult mouse β-cells. Mol Metab 3:803–812CrossRefPubMedCentralPubMed
37.
go back to reference Rondas D, Tomas A, Halban PA (2011) Focal adhesion remodeling is crucial for glucose-stimulated insulin secretion and involves activation of focal adhesion kinase and paxillin. Diabetes 60:1146–1157CrossRefPubMedCentralPubMed Rondas D, Tomas A, Halban PA (2011) Focal adhesion remodeling is crucial for glucose-stimulated insulin secretion and involves activation of focal adhesion kinase and paxillin. Diabetes 60:1146–1157CrossRefPubMedCentralPubMed
38.
go back to reference Radtke S, Milanovic M, Rosse C et al (2013) ERK2 but not ERK1 mediates HGF-induced motility in non-small cell lung carcinoma cell lines. J Cell Sci 126:2381–2391CrossRefPubMed Radtke S, Milanovic M, Rosse C et al (2013) ERK2 but not ERK1 mediates HGF-induced motility in non-small cell lung carcinoma cell lines. J Cell Sci 126:2381–2391CrossRefPubMed
39.
go back to reference Wendt A, Speidel D, Danielsson A et al (2012) Synapsins I and II are not required for insulin secretion from mouse pancreatic β-cells. Endocrinology 153:2112–2119CrossRefPubMed Wendt A, Speidel D, Danielsson A et al (2012) Synapsins I and II are not required for insulin secretion from mouse pancreatic β-cells. Endocrinology 153:2112–2119CrossRefPubMed
40.
go back to reference Krueger KA, Ings EI, Brun AM, Landt M, Easom RA (1999) Site-specific phosphorylation of synapsin I by Ca2+/calmodulin-dependent protein kinase II in pancreatic betaTC3 cells: synapsin I is not associated with insulin secretory granules. Diabetes 48:499–506CrossRefPubMed Krueger KA, Ings EI, Brun AM, Landt M, Easom RA (1999) Site-specific phosphorylation of synapsin I by Ca2+/calmodulin-dependent protein kinase II in pancreatic betaTC3 cells: synapsin I is not associated with insulin secretory granules. Diabetes 48:499–506CrossRefPubMed
41.
go back to reference MacDonald PE, Obermuller S, Vikman J et al (2005) Regulated exocytosis and kiss-and-run of synaptic-like microvesicles in INS-1 and primary rat β-cells. Diabetes 54:736–743CrossRefPubMed MacDonald PE, Obermuller S, Vikman J et al (2005) Regulated exocytosis and kiss-and-run of synaptic-like microvesicles in INS-1 and primary rat β-cells. Diabetes 54:736–743CrossRefPubMed
42.
go back to reference Bergeron A, Pucci L, Bezzi P, Regazzi R (2014) Analysis of synaptic-like microvesicle exocytosis of β-cells using a live imaging technique. PLoS One 9:e87758CrossRefPubMedCentralPubMed Bergeron A, Pucci L, Bezzi P, Regazzi R (2014) Analysis of synaptic-like microvesicle exocytosis of β-cells using a live imaging technique. PLoS One 9:e87758CrossRefPubMedCentralPubMed
43.
go back to reference Roskoski R Jr (2012) MEK1/2 dual-specificity protein kinases: structure and regulation. Biochem Biophys Res Commun 417:5–10CrossRefPubMed Roskoski R Jr (2012) MEK1/2 dual-specificity protein kinases: structure and regulation. Biochem Biophys Res Commun 417:5–10CrossRefPubMed
44.
go back to reference Benner C, van der Meulen T, Caceres E et al (2014) The transcriptional landscape of mouse beta cells compared to human beta cells reveals notable species differences in long non-coding RNA and protein-coding gene expression. BMC Genomics 15:620CrossRefPubMedCentralPubMed Benner C, van der Meulen T, Caceres E et al (2014) The transcriptional landscape of mouse beta cells compared to human beta cells reveals notable species differences in long non-coding RNA and protein-coding gene expression. BMC Genomics 15:620CrossRefPubMedCentralPubMed
45.
go back to reference Barker CJ, Li L, Kohler M, Berggren PO (2015) Beta-cell Ca2+ dynamics and function are compromised in aging. Adv Biol Regul 57:112–119CrossRefPubMed Barker CJ, Li L, Kohler M, Berggren PO (2015) Beta-cell Ca2+ dynamics and function are compromised in aging. Adv Biol Regul 57:112–119CrossRefPubMed
46.
go back to reference Atkinson MA, Leiter EH (1999) The NOD mouse model of type 1 diabetes: as good as it gets? Nat Med 5:601–604CrossRefPubMed Atkinson MA, Leiter EH (1999) The NOD mouse model of type 1 diabetes: as good as it gets? Nat Med 5:601–604CrossRefPubMed
47.
go back to reference Omar BA, Vikman J, Winzell MS et al (2013) Enhanced beta cell function and anti-inflammatory effect after chronic treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin in an advanced-aged diet-induced obesity mouse model. Diabetologia 56:1752–1760CrossRefPubMed Omar BA, Vikman J, Winzell MS et al (2013) Enhanced beta cell function and anti-inflammatory effect after chronic treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin in an advanced-aged diet-induced obesity mouse model. Diabetologia 56:1752–1760CrossRefPubMed
48.
go back to reference Ehses JA, Perren A, Eppler E et al (2007) Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 56:2356–2370CrossRefPubMed Ehses JA, Perren A, Eppler E et al (2007) Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 56:2356–2370CrossRefPubMed
49.
go back to reference Fischer AM, Katayama CD, Pages G, Pouyssegur J, Hedrick SM (2005) The role of ERK1 and ERK2 in multiple stages of T cell development. Immunity 23:431–443CrossRefPubMed Fischer AM, Katayama CD, Pages G, Pouyssegur J, Hedrick SM (2005) The role of ERK1 and ERK2 in multiple stages of T cell development. Immunity 23:431–443CrossRefPubMed
Metadata
Title
ERK1 is dispensable for mouse pancreatic beta cell function but is necessary for glucose-induced full activation of MSK1 and CREB
Authors
Michele Leduc
Joy Richard
Safia Costes
Dany Muller
Annie Varrault
Vincent Compan
Julia Mathieu
Jean-François Tanti
Gilles Pagès
Jacques Pouyssegur
Gyslaine Bertrand
Stéphane Dalle
Magalie A. Ravier
Publication date
01-10-2017
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 10/2017
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-017-4356-6

Other articles of this Issue 10/2017

Diabetologia 10/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.